Document

Clinical Laboratory Improvement Advisory Committee (CLIAC): Meeting

[Federal Register Volume 63, Number 167 (Friday, August 28, 1998)] [Notices] [Pages 46052-46053] From the Federal Register Online via the Government Publishing Office [ www.gpo....

[Federal Register Volume 63, Number 167 (Friday, August 28, 1998)]
[Notices]
[Pages 46052-46053]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-23131]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC): 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.
    Name: Clinical Laboratory Improvement Advisory Committee (CLIAC).
    Times and Dates: 8:30 a.m.-5 p.m., September 16, 1998; 8:30 a.m.-5 
p.m., September 17, 1998.
    Place: CDC, Koger Center, Williams Building, Conference Rooms 1802 
and 1805, 2877 Brandywine Road, Atlanta, Georgia 30341.
    Status: Open to the public, limited only by the space available. 
The meeting rooms accommodate approximately 85 people.
    Purpose: This committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the standards 
under which clinical laboratories are regulated; the impact of proposed 
revisions to the standards; and the modification of the standards to 
accommodate technological advances.
    Matters To Be Discussed: The agenda will include an update on CLIA 
implementation; a report from the Genetic Testing Workgroup and 
discussions of revisions to general or specific CLIA requirements that 
apply to pre-analytic, analytic, and post-analytic components of 
genetic testing; and the applicability of CLIA to laboratory testing 
performed for assisted reproductive technology (ART).
    Agenda items are subject to change as priorities dictate.

CONTACT PERSON FOR ADDITIONAL INFORMATION: John C. Ridderhof, Dr.

[[Page 46053]]

P.H., Division of Laboratory Systems, Public Health Practice Program 
Office, CDC, 4770 Buford Highway, NE, Mailstop G-25, Atlanta, Georgia 
30341-3724, telephone 770/488-8076, FAX 770/488-8282.

    Dated: August 24, 1998.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 98-23131 Filed 8-27-98; 8:45 am]
BILLING CODE 4163-18-P


Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

63 FR 46052

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Clinical Laboratory Improvement Advisory Committee (CLIAC): Meeting,” thefederalregister.org (August 28, 1998), https://thefederalregister.org/documents/98-23131/clinical-laboratory-improvement-advisory-committee-cliac-meeting.